Chikungunya lgM antibodies are specific proteins produced by the immune system in response to a Chikungunya virus infection. These antibodies typically become detectable in the blood about 3 to 7 days after the onset of symptoms. The presence of Chikungunya lgM is a key marker for diagnosing an acute or recent infection.

Serological testing for lgM is essential because the clinical symptoms of Chikungunya - such as high fever, rash, and debilitating joint pain - closely resemble those of other mosquito-borne diseases like Dengue and Zika. A positive lgM result helps healthcare providers differentiate Chikungunya from these other conditions, enabling appropriate patient management. Since lgM levels usually persist for several months before declining, the test is most effective during the sub-acutephase. This distinction is crucial for clinical care, as Chikungunya often requires specific management for chronic joint pain, unlike Dengue, which carries risks of hemorrhage.

Product Advantages: 

Fast Results in 15 Minutes

Easy Visual Interpretation

Convenient Procedure

High Accuracy